SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-020763
Filing Date
2021-08-23
Accepted
2021-08-23 18:32:58
Documents
2
Period of Report
2021-08-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 CHERRINGTON rdgdoc.html 4  
1 FORM 4 CHERRINGTON rdgdoc.xml 4 3626
2 cherrington.htm EX-24 8017
  Complete submission text file 0001437749-21-020763.txt   13329
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9393 TOWNE CENTRE DRIVE STE 200 SAN DIEGO CA 92121
Business Address
Cherrington Julie M (Reporting) CIK: 0001781315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 211198090